Details of the Drug

General Information of Drug (ID: DM2YQK8)

Drug Name

AR-301

Indication

Disease Entry	ICD 11	Status	REF
Ventilator-associated pneumonia	PK81.0	Phase 3	[1]
Hospital-acquired pneumonia	CA40.Z	Phase 2	[2]
Pneumonia	CA40	Phase 1/2	[3]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

Repurposed Drugs (RPD)

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Staphylococcus Alpha-hemolysin (Stap-coc hly)	TT5FLYB	HLA_STAAU	Inhibitor	[4]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT03816956) Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301 (AR-301-002). U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT01589185) Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus). U.S. National Institutes of Health.
3	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800036003)
4	Clinical pipeline report, company report or official report of Aridis Pharmaceuticals.